Articles tagged "HIV virus"

2019 American Transplant Congress
Analysis Of Public Health Service Increased Risk Donors Shows No Viral Transmission In Liver Transplant Recipients And Similar Graft / Patient Survival When Compared To Non-increased Risk Donors
A. Amin, T. Ito, D. Ng, R. McMillan, J. DiNorcia, V. Agopian, F. Kaldas, H. Yersiz, R. Busuttil, D. Farmer
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Public Health Service increased risk donors (PHS-IRD) are underutilized in liver transplant (LT) due to concern for transmission of viral (HBV, HCV, and HIV)…
2019 American Transplant Congress
Hope in Action: A Multicenter Prospective Study of HIV to HIV Kidney Transplantation
C. Durand¹, S. Huprikar², M. Bowring³, D. Brown¹, B. Haydel⁴, N. Desai³, F. Naqvi¹, R. Friedman-Moraco⁵, N. Turgeon⁶, V. Stosor⁷, J. Charette⁷, S. Mehta⁸, J. Husson⁹, A. Gilbert¹⁰, M. Cooper¹¹, C. Butkus-Small¹², G. Gupta¹³, S. Mehta¹⁴, O. Adebiyi¹⁵, P. Chin-Hong¹⁶, P. Stock¹⁷, A. Massie³, S. Florman⁴, D. Segev³
¹Medicine, Johns Hopkins University, Baltimore, MD, ²Medicine, Mount Sinai, New York, NY, ³Surgery, Johns Hopkins University, Baltimore, MD, ⁴Surgery, Mount Sinai, New York, NY, ⁵Medicine, Emory University, Atlanta, GA, ⁶Surgery, Emory University, Atlanta, GA, ⁷Medicine, Northwestern University, Chicago, IL, ⁸Medicine, University of Alabama, Birmingham, AL, ⁹Medicine, University of Maryland, Baltimore, MD, ¹⁰Medicine, Georgetown University, Washington DC, DC, ¹¹Department of Surgery, Georgetown University, Washington DC, DC, ¹²Medicine, Cornell University, New York, NY, ¹³Medicine, Virginia Commonwealth University, Richmond, VA, ¹⁴Medicine, New York University, New York, NY, ¹⁵Medicine, Indiana University, Indianapolis, IN, ¹⁶Medicine, University of California at San Francisco, San Francisco, CA, ¹⁷Surgery, University of California at San Francisco, San Francisco, CA
*Purpose:HIV+ donor to HIV+ recipient (HIV D+/R+) kidney transplantation (KT) has had success in South Africa. Expansion of this practice in the US setting of…
2019 American Transplant Congress
Characterization Of Increased Risk Donor Post-transplant Viral Surveillance Protocol At A Comprehensive Transplant Center
J. Dann, W. Ally, S. Pelletier, C. Sifri, A. Agarwal
University of Virginia Health System, Charlottesville, VA
*Purpose: With the growing opioid crisis, the number of deceased donors classified as Increased Risk Donor (IRD) has increased to nearly 20% nationally. The Organ…
2019 American Transplant Congress
Hope Act Donors With Organs Recovered For Transplant: The First Two Years
W. A. Werbel, O. Kusemiju, B. Barnaba, M. Bowring, B. Doby, C. Kirby, R. Fernandez, Y. Eby, J. Miller, D. Brown, S. Seaman, D. Ostrander, A. Tobian, D. Segev, C. M. Durand
Johns Hopkins University, Baltimore, MD
*Purpose: The HOPE Act expands the potential deceased donor pool to include HIV+ donors (HIV D+) and donors with false-positive (FP) HIV screens. The objective…
2019 American Transplant Congress
Long Term Outcomes of Patients Transplanted for Hepatocellular Carcinoma with Human Immunodeficiency Virus Infection
R. Gedaly-Eidelman, E. Chacon, P. Eman, M. Gupta, J. Berger, A. El-Husseini, X. Mei, F. Marti, L. Turcios, M. Shah
University of Kentucky, Lexington, KY
*Purpose: Several studies have reported that HIV+ patients are 4-6 times more likely to develop HCC than uninfected individuals. Our aim was to assess outcomes…
2019 American Transplant Congress
A Single-Center Experience with a 6-Month Regimen of Pneumocystis jiroveci Pneumonia Prophylaxis in HIV-Positive Kidney Transplant Recipients
C. Mejia¹, G. Malat², D. H. Lee³, S. Epstein¹, M. Harhay³, L. Levin Mizrahi³, K. Ranganna³
¹Drexel University, Philadelphia, PA, ²Hahnemann University Hospital, Philadelphia, PA, ³Medicine, Drexel University, Philadelphia, PA
*Purpose: Pneumocystis jiroveci pneumonia (PJP) prophylaxis is recommended for all kidney transplant recipients (KTR) for after transplant. HIV-positive KTRs represent a unique subset, and there…
2019 American Transplant Congress
Barriers to Kidney Transplant Wait Listing among HIV Positive Patients with Advanced Kidney Disease
S. M. Boyle¹, K. Fehr¹, C. Deering², A. Raza¹, M. Harhay¹, G. Malat³, K. Ranganna¹, D. Lee¹
¹Drexel University, Philadelphia, PA, ²University of Toledo, Toledo, OH, ³Hahnemann University Hospital, Philadelphia, PA
*Purpose: Compared to HIV-negative kidney transplant (KT) candidates, the median time to waiting list activation is longer among HIV-positive candidates. Little is known about potential…
2019 American Transplant Congress
The Spread of HIV Donation throughout a DSA
A. Friedman, E. Marquez, J. A. Lewis, K. Delli Carpini
LiveOnNY, New York, NY
*Purpose: Before passage of the HOPE act in late 2013, HIV infection was an absolute contraindication to organ donation. Retrospective review of the records of…
2019 American Transplant Congress
Impact of Everolimus Therapy on HIV Persistence and Gene Expression in Transplant Patients
A. Zarinsefat¹, C. Schreiner¹, C. Cameron², S. Chu¹, M. P. Busch¹, T. Liegler¹, S. G. Deeks¹, T. J. Henrich¹, P. G. Stock¹
¹UC San Francisco, San Francisco, CA, ²Case Western Reserve University, Cleveland, OH
*Purpose: mTOR is a key regulatory kinase that controls cell-cycle progression. mTOR inhibitors have been shown to reduce expression of CCR5 and promote viral transcriptional…
2019 American Transplant Congress
The National Landscape of Heart Transplant Candidates with HIV
A. A. Shaffer¹, A. G. Thomas², D. L. Segev¹
¹Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC
*Purpose: Heart disease is a leading cause of death for HIV+ individuals, and the number of HIV+ heart transplant (HT) recipients is growing. Although understanding…